1. Abbruzzese M. Multifocal motor neuropathy with conduction block after Campylobacter jejuni enteritis. Neurology 1997 Feb 48: 544-MID.
  2. Adams RD, Asbury AK, Michelsen JJ. Multifocal pseudohypertrophic neuropathy. Trans Am Neurol Assoc 1965; 90: 30-32.
  3. Al Lozi M, Pestronk A. Organ-specific autoantibodies with muscle weakness. Curr Opin Rheumatol 1999; 11: 483-488.
  4. Alaedini A, Latov N. Detection of anti-GM1 ganglioside antibodies in patients with neuropathy by a novel latex agglutination assay. J Immunoassay 2000; 21: 377-386.
  5. Alaedini A, Latov N. A surface plasmon resonance biosensor assay for measurement of anti- GM(1) antibodies in neuropathy. Neurology 2001; 56: 855-860.
  6. Alaedini A, Wirguin I, Latov N. Ganglioside agglutination immunoassay for rapid detection of autoantibodies in immune-mediated neuropathy. J Clin Lab Anal 2001; 15: 96-99.
  7. Arasaki K, Kusunoki S, Kudo N, Kanazawa I. Acute conduction block in vitro following exposure to antiganglioside sera. Muscle Nerve 1993; 16: 587-593.
  8. Ariga T, Miyatake T, Yu RK. Recent studies on the roles of antiglycosphingolipids in the pathogenesis of neurological disorders. J Neurosci Res 2001; 65: 363-370.
  9. Auer RN, Bell RB, Lee MA. Neuropathy with onion bulb formation and pure motor manifestations. Can J Neurol Sci 1989; 16: 194-197.
  10. Azulay J-P, Blin O, Pouget J, Boucraut J, Billé-Turc F, Carles G, Serratrice G. Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: A double-blind, placebo-controlled study. Neurology 1994; 44: 429-432.
  11. Azulay JP. Long term follow up of multifocal motor neuropathy with conduction block under treatment. J Neurol Neurosurg Psychiatry 1997; 62: 391-394.
  12. Azulay JP, Attarian S, Boucraut J, Pouget J. [Lower motor neuron disease and signs of dysimmunity]. Rev Neurol (Paris) 2000; 156: 372-379.
  13. Baumann N, Harpin ML, Marie Y, Lemerle K, Chassande B, Bouche P, Meininger V, Yu RK, Leger JM. Antiglycolipid antibodies in motor neuropathies. Ann N Y Acad Sci 1998; 845: 322-329.
  14. Bech E. Association of IgM type anti-GM1 antibodies and muscle strength in chronic acquired demyelinating polyneuropathy. Ann Neurol 1998 Jan 43: 72-78.
  15. Benatar M, Willison HJ, Vincent A. Immune-mediated peripheral neuropathies and voltage-gated sodiums channels. Muscle Nerve 1999; 22: 108-110.
  16. Bentes C, de Carvalho M, Evangelista T, Sales-Luis ML. Multifocal motor neuropathy mimicking motor neuron disease: nine cases. J Neurol Sci 1999; 169: 76-79.
  17. Berg-Vos RM, Franssen H, Wokke JH, van Es HW, van den Berg LH. Multifocal motor neuropathy: diagnostic criteria that predict the response to immunoglobulin treatment. Ann Neurol 2000; 48: 919-926.
  18. Berg-Vos RM, van den Berg LH, Franssen H, Van Doorn PA, Merkies IS, Wokke JH. Treatment of multifocal motor neuropathy with interferon-beta1A. Neurology 2000; 54: 1518-1521.
  19. Berg-Vos RM, van den Berg LH, Franssen H, Vermeulen M, Witkamp TD, Jansen GH, van Es HW, Kerkhoff H, Wokke JH. Multifocal inflammatory demyelinating neuropathy: a distinct clinical entity? Neurology 2000; 54: 26-32.
  20. Beydoun SR. Multifocal motor neuropathy with conduction block misdiagnosed as multiple entrapment neuropathies. Muscle Nerve 1998; 21: 813-815.
  21. Beydoun SR, Copeland D. Bilateral phrenic neuropathy as a presenting feature of multifocal motor neuropathy with conduction block. Muscle Nerve 2000; 23: 556-559.
  22. Beydoun SR, Rison RA, Commins D. Secondary amyloidosis as a life-ending event in multifocal motor neuropathy. Muscle Nerve 2001; 24: 1396-1402.
  23. Biessels GJ. Multifocal motor neuropathy. J Neurol 1997; 244: 143-152.
  24. Boonyapisit K, Katirji B. Multifocal motor neuropathy presenting with respiratory failure. Muscle Nerve 2000; 23: 1887-1890.
  25. Bouche P, Le Forestier N, maisonobe t, Fournier E, Willer JC. Electrophysiological diagnosis of motor neuron disease and pure motor neuropathy. J Neurol 1999; 246: 520-525.
  26. Bouche P, Moulonguet A, Ben Younes-Chennoufi A, Adams D, Baumann N, Meininger V, Leger J-M, Said G. Multifocal motor neuropathy with conduction block: a study of 24 patients. J Neurol Neurosurg Psychiatry 1995; 59: 38-44.
  27. Bradley WG, Bennett RK, Good P, Little B. Proximal chronic inflammatory polyneuropathy with multifocal conduction block. Arch Neurol 1988; 45: 451-455.
  28. Bril V, Allenby K, Midroni G, O'Connor PW, Vajsar J. IGIV in neurology--evidence and recommendations. Can J Neurol Sci 1999; 26: 139-152.
  29. Busby M, Donaghy M. Predominant arm weakness in acute idiopathic polyneuritis: a distinct regional variant. J Neurol 2000; 247: 343-345.
  30. Cammarota A, Nogues M, Rivero A, Garcia H. [Multifocal motor neuropathy. Immediate response to intravenous immunoglobulin]. Medicina (B Aires) 2001; 61: 441-444.
  31. Cappelen-Smith C, Kuwabara S, Lin CS, Mogyoros I, Burke D. Activity-dependent hyperpolarization and conduction block in chronic inflammatory demyelinating polyneuropathy. Ann Neurol 2000; 48: 826-832.
  32. Cappellari A. Criteria for early detection of conduction block in multifocal motor neuropathy (MMN): a study based on control populations and follow-up of MMN patients. J Neurol 1997 Oct 244: 625-630.
  33. Carpo M. Deterioration of multifocal motor neuropathy after plasma exchange. Neurology 1998 May 50: 1480-1482.
  34. Carpo M, Allaria S, Scarlato G, Nobile-Orazio E. Marginally improved detection of GM1 antibodies by Covalink ELISA in multifocal motor neuropathy. Neurology 1999; 53: 2206-2207.
  35. Chad DA, Hammer K, Sargent J. Slow resolution of multifocal weakness and fasciculations: a reversible motor neuron syndrome. Neurology 1986; 36: 1260-1263.
  36. Charles N, Vial C, Benoit P, Bierme T, Bady B. Intravenous immunoglobulin treatment in multifocal motor neuropathy. Lancet 1992; 340: 182.
  37. Chaudhry V. Multifocal motor neuropathy. Semin Neurol 1998; 18: 73-81.
  38. Chaudhry V, Corse AM, Cornblath DR, Kuncl RW, Drachman DB, Freimer ML, Miller RG, Griffin JW. Multifocal motor neuropathy: Response to human immune globulin. Ann Neurol 1993; 33: 237-242.
  39. Chaudhry V, Corse AM, Cornblath DR, Kuncl RW, Freimer ML, Griffin JW. Multifocal motor neuropathy: Electrodiagnostic features. Muscle Nerve 1994; 17: 198-205.
  40. Claus D, Specht S, Zieschang M. Plasmapheresis in multifocal motor neuropathy: a case report. J Neurol Neurosurg Psychiatry 2000; 68: 533-535.
  41. Comi G, Amadio S, Galardi G, Fazio R, Nemni R. Clinical and neurophysiological assessment of immunoglobulin therapy in five patients with multifocal motor neuropathy. J Neurol Neurosurg Psychiatry 1994; 57(Suppl): 35-37.
  42. Corse AM, Chaudhry V, Crawford TO, Cornblath DR, Kuncl RW, Griffin JW. Demyelinating pathology in sural nerves in multifocal motor neuropathy. Ann Neurol 1996; 39: 319-325.
  43. Donaghy M, Mills KR, Boniface SJ, Simmons J, Wright I, Gregson N, Jacobs J. Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin. J Neurol Neurosurg Psychiatry 1994; 57: 778-783.
  44. Elliott JL, Pestronk A. Progression of multifocal motor neuropathy during apparently successful treatment with human immunoglobulin. Neurology 1994; 44: 967-968.
  45. Ellis CM, Leary S, Payan J, Shaw C, Hu M, O'Brien M, Leigh PN. Use of human intravenous immunoglobulin in lower motor neuron syndromes. J Neurol Neurosurg Psychiatry 1999; 67: 15-19.
  46. Federico P, Zochodne DW, Hahn AF, Brown WF, Feasby TE. Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study. Neurology 2000; 55: 1256-1262.
  47. Feldman EL, Bromberg MB, Albers JW, Pestronk A. Immunosuppressive treatment in multifocal motor neuropathy. Ann Neurol 1991; 30: 397-401.
  48. Finsterer J, Derfler K. Immunoadsorption in multifocal motor neuropathy. J Immunother 1999; 22: 441-442.
  49. Gallardo E, Rojas-Garcia R, Belvis R, Serrano-Munuera C, Ortiz E, Ortiz N, Grau J, Illa I. [Antiganglioside antibodies: when, which and for what]. Neurologia 2001; 16: 293-297.
  50. Gallardo E, Rojas R, Illa I. [Relevant antibodies in dysimmune neuropathies]. Rev Neurol 2000; 30: 510-514.
  51. Ge XX, Spector GJ, Carr CC. The pathophysiology of compression injuries of the peripheral facial nerve. Laryngoscope 1982; 92(Suppl 31): 1-15.
  52. Gorson KC, Ropper AH, Weinberg DH. Upper limb predominant, multifocal chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 1999; 22: 758-765.
  53. Gutierrez Ronquillo JH, Andrade MR, Machado RA, Garcia EA. [Multifocal motor neuropathy with partial block of nerve conduction]. Rev Neurol 2001; 32: 427-430.
  54. Hadden RD, Hughes RA. Treatment of immune-mediated inflammatory neuropathies. Curr Opin Neurol 1999; 12: 573-579.
  55. Hahn AF. [Acquired demyelinating neuropathies]. Rev Prat 2000; 50: 724-730.
  56. Harvey GK, Toyka KV, Zielasek J, Kiefer R, Simonis C, Hartung H-P. Failure of anti-GM1 IgG or IgM to induce conduction block following intraneural transfer. Muscle Nerve 1995; 18: 388-394.
  57. Hirota N. The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons. Brain 1997 Dec 120: 2159-2169.
  58. Hughes PR. 79(th) ENMC International Workshop: multifocal motor neuropathy. 14-15 April 2000, Hilversum, The Netherlands. Neuromuscul Disord 2001; 11: 309-314.
  59. Hughes RA. Pathogenesis and treatment of inflammatory demyelinating polyradiculoneuropathy. Acta Neurol Belg 2000; 100: 167-170.
  60. Jaspert A, Claus D, Grehl H, Neundörfer B. Multifocal motor neuropathy: clinical and electrophysiological findings. J Neurol 1996; 243: 684-692.
  61. Kaji R, Bostock H, Kohara N, Murase N, Kimura J, Shibasaki H. Activity-dependent conduction block in multifocal motor neuropathy. Brain 2000; 123 ( Pt 8): 1602-1611.
  62. Kaji R, Oka N, Tsuji T, Mezaki T, Nishio T, Akiguchi I, Kumura J. Pathological findings at the site of conduction block in multifocal motor neuropathy. Ann Neurol 1993; 33: 152-158.
  63. Kaji R, Shibasaki H, Kimura J. Multifocal demyelinating motor neuropathy: Cranial nerve involvement and immunoglobulin therapy. Neurology 1992; 42: 506-509.
  64. Katz JS. Electrophysiologic findings in multifocal motor neuropathy. Neurology 1997; 48: 700-707.
  65. Katz JS, Saperstein DS. Asymmetric Acquired Demyelinating Polyneuropathies: MMN and MADSAM. 2001; 3: 119-125.
  66. Komiyama A. Multifocal motor neuropathy. Neurology 1998 Jan 50: 314-315.
  67. Krarup C, Stewart JD, Sumner AJ, Pestronk A, Lipton SA. A syndrome of asymmetrical limb weakness and motor conduction block. Neurology 1990; 40: 118-127.
  68. Kubori T, Mezaki T, Kaji R, Kimura J, Hamaguchi K, Hirayama K, Kanazawa I, Miyatake T, Mannen T, Kowa H, Yanagisawa N, Goto I, Osame M, Kanda M, Tashiro K, Baba M, Kuroiwa Y, Nagatomo H, Mitsuma T, Shigeta Y, Saida T, Nakajima K, Kawamura J, Murai Y, Kiuchi T, . [The clinical usefulness of high-dose intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy]. No To Shinkei 1999; 51: 127-135.
  69. Lagueny A. Single fibre electromyography in multifocal motor neuropathy with persistent conduction blocks. J Neurol Neurosurg Psychiatry 1998 Sep 65: 357-361.
  70. Lange DJ, Trojaborg W, Latov N, Hays AP, Younger DS, Uncini A, Blake DM, Hirano M, Burns SM, Lovelace RE, Rowland LP. Multifocal motor neuropathy with conduction block: Is it a distinct clinical entity? Neurology 1992; 42: 497-505.
  71. Latov N, Chaudhry V, Koski CL, Lisak RP, Apatoff BR, Hahn AF, Howard JF, Jr. Use of intravenous gamma globulins in neuroimmunologic diseases. J Allergy Clin Immunol 2001; 108: 126S-132S.
  72. Leger JM, Ben Younes-Chennoufi A, Chassande B, Davila G, Bouche P, Baumann N, Brunet P. Human immunoglobulin treatment of multifocal motor neuropathy and polyneuropathy associated with monoclonal gammopathy. J Neurol Neurosurg Psychiatry 1994; 57(Suppl): 46-49.
  73. Leger JM, Chassande B. [Treatment of chronic immune-mediated polyneuropathies. State of the art and perspectives]. Ann Med Interne (Paris) 2000; 151 Suppl 1: 1S19-1S23.
  74. Leger JM, Chassande B, Musset L, Meininger V, Bouche P, Baumann N. Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study. Brain 2001; 124: 145-153.
  75. Leger JM, Salachas F. Diagnosis of motor neuropathy. Eur J Neurol 2001; 8: 201-208.
  76. Lewis RA. Multifocal motor neuropathy and Lewis Sumner syndrome: two distinct entities. Muscle Nerve 1999; 22: 1738-1739.
  77. Lewis RA, Sumner AJ, Brown MJ, Asbury AK. Multifocal demyelinating neuropathy with persistent conduction block. Neurology 1982; 32: 958-964.
  78. Magistris M, Roth G. Motor neuropathy with multifocal persistent conduction blocks. Muscle Nerve 1992; 15: 1056.
  79. Martina IS, Van Doorn PA, Schmitz PI, Meulstee J, van der Meche FG. Chronic motor neuropathies: response to interferon-beta1a after failure of conventional therapies. J Neurol Neurosurg Psychiatry 1999; 66: 197-201.
  80. McCombe PA, Wilson R, Prentice RL. Results of testing for anti-GM1 antibodies. J Clin Neurosci 2000; 7: 209-212.
  81. Meucci N. Long term effect of intravenous immunoglobulins and oral cyclophosphamide in multifocal motor neuropathy. J Neurol Neurosurg Psychiatry 1997; 63: 765-769.
  82. Mezaki T, Kaji R, Kimura J. Multifocal motor neuropathy and Lewis Sumner syndrome: a clinical spectrum. Muscle Nerve 1999; 22: 1739-1740.
  83. Misra VP, Walker RW. Acute-onset painful upper limb multifocal demyelinating motor neuropathy. J Neurol 2000; 247: 949-954.
  84. Molinuevo JL, Cruz-Martinez A, Graus F, Serra J, Ribalta T, Valls-Sole J. Central motor conduction time in patients with multifocal motor conduction block. Muscle Nerve 1999; 22: 926-932.
  85. Niebroj-Dobosz I, Mickielewicz A, Rowinska-Marcinska K, Kwiecinski H. Identification of Gal(beta 1-3)GalNAc bearing glycoproteins in cerebrospinal fluid of amyotrophic lateral sclerosis (ALS) patients. Eur J Neurol 2000; 7: 679-683.
  86. Nobile-Orazio E. Multifocal motor neuropathy. J Neuroimmunol 2001; 115: 4-18.
  87. Nobile-Orazio E, Carpo M, Meucci N. Are there immunologically treatable motor neuron diseases? Amyotroph Lateral Scler Other Motor Neuron Disord 2001; 2 Suppl 1: S23-S30.
  88. Nobile-Orazio E, Meucci N. High-dose intravenous immunoglobulin in multifocal motor neuropathy. Electroencephalogr Clin Neurophysiol Suppl 1999; 50: 506-513.
  89. Nobile-Orazio E, Meucci N, Barbieri S, Carpo M, Scarlato G. High-dose intravenous immunoglobulin therapy in multifocal motor neuropathy. Neurology 1993; 43: 537-544.
  90. Pakiam AS. Multifocal motor neuropathy without overt conduction block. Muscle Nerve 1998 Feb 21: 243-245
  91. Paparounas K, O'Hanlon GM, O'Leary CP, Rowan EG, Willison HJ. Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro [see comments]. Brain 1999; 122 ( Pt 5): 807-816.
  92. Parry GJ. AAEM case report #30: multifocal motor neuropathy. Muscle Nerve 1996 Mar 19: 269-276.
  93. Parry GJ. Are multifocal motor neuropathy and Lewis-Sumner syndrome distinct nosologic entities? Muscle Nerve 1999; 22: 557-559.
  94. Parry GJ, Clarke S. Multifocal acquired neuropathy masquerading as motor neuron disease. Muscle Nerve 1988; 11: 103-107.
  95. Pelliccioni G. Amyotrophic lateral sclerosis and multifocal motor neuropathy with conduction block. J Neurol Sci 1997 Nov 6 152: 109-110.
  96. Pestronk A. Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates. Neurology 1997 Nov 49: 1289-1292.
  97. Pestronk A. Multifocal motor neuropathy: diagnosis and treatment. Neurology 1998 Dec 51: S22-S24.
  98. Pestronk A, Chaudhry V, Feldman EL, Griffin JW, Cornblath DR, Denys EH, Glasberg M, Kuncl RW, Olney RK, Yee WC. Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies. Ann Neurol 1990; 27: 316-326.
  99. Pestronk A, Cornblath DR, Ilyas AA, Baba H, Quarles RH, Griffin JW, Alderson K, Adams RN. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol 1988; 24: 73-78.
  100. Pfeiffer G, Wicklein EM, Wittig K. Sensitivity and specificity of different conduction block criteria. Clin Neurophysiol 2000; 111: 1388-1394.
  101. Rizk A, Gorson KC, Kenney L, Weinstein R. Transfusion-related acute lung injury after the infusion of IVIG. Transfusion 2001; 41: 264-268.
  102. Roberts M, Willison HJ, Vincent A, Newsom-Davis J. Multifocal motor neuropathy human sera block distal motor nerve conduction in mice. Ann Neurol 1995; 38: 111-118.
  103. Rosler KM. Electrophysiologic findings in multifocal motor neuropathy. Neurology 1998 Jun 50: 1936-1937.
  104. Roth RG, Rohr J, Magistris MR, Ochsner F. Motor neuropathy with proximal multifocal persistent conduction block, fasciculations, and myokymia: Evolution to tetraplegia. Eur Neurol 1986; 25: 416-423.
  105. Santoro M, Uncini A, Corbo M, Staugaitis SM, Thomas FP, Hays AP, Latov N. Experimental conduction block induced by serum from a patient with anti-GM1 antibodies. Ann Neurol 1992; 31: 385-390.
  106. Saperstein DS, Amato AA, Wolfe GI, Katz JS, Nations SP, Jackson CE, Bryan WW, Burns DK, Barohn RJ. Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome. Muscle Nerve 1999; 22: 560-566.
  107. Saperstein DS, Katz JS, Amato AA, Barohn RJ. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 2001; 24: 311-324.
  108. Seoane JL, Espadaler JM, Tellez MJ. [Chronic demyelinating auto-immune acquired neuropathy: Lewis-Sumner syndrome]. Rev Neurol 2000; 30: 525-528.
  109. Stangel M, Toyka KV, Gold R. Mechanisms of high-dose intravenous immunoglobulins in demyelinating diseases. Arch Neurol 1999; 56: 661-663.
  110. Takigawa T, Yasuda H, Kikkawa R. Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelinated nerve fibers. Ann Neurol 1995; 37: 436-442.
  111. Tan E, Lynn DJ, Amato AA, Kissel JT, Rammohan KW, Sahenk Z, Warmolts JR, Jackson CE, Barohn RJ, Mendell JR. Immunosuppressive treatment of motor neuron syndromes. Attempts to distinguish a treatable disorder. Arch Neurol 1994; 51: 194-200.
  112. Taylor BV, Wright RA, Harper CM, Dyck PJ. Natural history of 46 patients with multifocal motor neuropathy with conduction block. Muscle Nerve 2000; 23: 900-908.
  113. Thomas FP, Trojaborg W, Nagy C, Santoro M, Sadiq SA, Latov N, Hays AP. Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier. Acta Neuropathol 1991; 82: 378-383.
  114. Thomas PK, Claus D, Jaspert A, Workman JM, King RHM, Larner AJ, Anderson M, Emerson JA, Ferguson DT. Focal upper limb demyelinating neuropathy. Brain 1996; 119: 765-774.
  115. Traba A, Esteban A. [Multifocal motor neuropathy]. Rev Neurol 2000; 30: 519-525.
  116. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Amyotrophic lateral sclerosis mimic syndromes: a population-based study. Arch Neurol 2000; 57: 109-113.
  117. Turnbull J. Multifocal motor neuropathy improved by IVIg. Neurology 2001; 56: 1608.
  118. Uncini A, Santoro M, Corbo M, Lugaresi A, Latov N. Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GM1 antibodies. Muscle Nerve 1993; 16: 610-615.
  119. Van den Berg LH eal. Improvement of multifocal motor neuropathy during long-term weekly treatment with human immunoglobulin. Neurology 1995 May 45: 987-988.
  120. Van den Berg LH eal. Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study. J Neurol Neurosurg Psychiatry 1995; 59: 248-252.
  121. Van den Berg LH eal. Pulsed high-dose dexamethasone is not effective in patients with multifocal motor neuropathy. Neurology 1997; 48: 1135-1MID.
  122. van den Berg LH, Franssen H, Wokke JHJ. The long-term effect of intravenous immunoglobulin treatment in multifocal motor neuropathy. Brain 1998; 121: 421-428.
  123. Van Doorn PA, van der Meche FG. IVIg treatment improves multifocal motor neuropathy: easy to start but difficult to stop. Neurology 2000; 55: 1246-1247.
  124. Van Es HW eal. Magnetic resonance imaging of the brachial plexus in patients with multifocal motor neuropathy. Neurology 1997 May 48: 1218-1224.
  125. van Es HW. MRI of the brachial plexus. Eur Radiol 2001; 11: 325-336.
  126. Vedeler CA. Inflammatory neuropathies: update. Curr Opin Neurol 2000; 13: 305-309.
  127. Verma A, Bradley WG. Atypical motor neuron disease and related motor syndromes. Semin Neurol 2001; 21: 177-187. 128. Yuki N. Possible mechanism of intravenous immunoglobulin treatment on anti-GM1 antibody-mediated neuropathies. J Neurol Sci 1996 Jul 139: 160-162.


© Copyright 2003 | All Rights Reserved  |  The Johns Hopkins University
JHOC Room 5072A  |  601 N. Wolfe Street  |  Baltimore, Maryland 21287 USA
410-955-9167 (tel)  |  410-614-8377 (fax)